Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Prognostic Impact of the Published European Society of Gynecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery

NCT07567573 is registered in ClinicalTrials.gov with European Society of Gynaecological Oncology as lead sponsor.

NCT NCT07567573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07567573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Prognostic Impact of the Published European Society of Gynecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Lead sponsor
European Society of Gynaecological Oncology
Phase
Observational
Overall status
Completed
Start date
April 26, 2023
Completion date
December 20, 2024
Enrollment
11,383 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced-stage ovarian cancer, d010051, figo stages iii and iv, ovarian cancer, quality indicators